These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 760598)

  • 1. Volatile metabolites and decomposition products of halothane in man.
    Sharp JH; Trudell JR; Cohen EN
    Anesthesiology; 1979 Jan; 50(1):2-8. PubMed ID: 760598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagenicity studies with volatile metabolites of halothane.
    Edmunds HN; Baden JM; Simmon VF
    Anesthesiology; 1979 Nov; 51(5):424-9. PubMed ID: 386857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting the formation of chlorotrifluoroethane and chlorodifluoroethylene from halothane.
    Maiorino RM; Sipes IG; Gandolfi AJ; Brown BR; Lind RC
    Anesthesiology; 1981 May; 54(5):383-9. PubMed ID: 7224207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reductive metabolism of halothane in children.
    Plummer JL; Van der Walt JH; Cousins MJ
    Anaesth Intensive Care; 1984 Nov; 12(4):293-5. PubMed ID: 6517287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic differences in reductive metabolism and hepatotoxicity of halothane in three rat strains.
    Gourlay GK; Adams JF; Cousins MJ; Hall P
    Anesthesiology; 1981 Aug; 55(2):96-103. PubMed ID: 7258721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-course of formation of volatile reductive metabolites of halothane in humans and an animal model.
    Gourlay GK; Adams JF; Cousins MJ; Sharp JH
    Br J Anaesth; 1980 Mar; 52(3):331-6. PubMed ID: 7370149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of mutagenicity of two possible metabolites of halothane.
    Waskell L
    Anesthesiology; 1979 Jan; 50(1):9-12. PubMed ID: 367217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenicity of the halogenated olefin, 2-bromo-2-chloro-1,1-difluoroethylene, a presumed metabolite of the inhalation anesthetic halothane.
    Garro AJ; Phillips RA
    Environ Health Perspect; 1977 Dec; 21():65-9. PubMed ID: 417917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of paraquat on biotransformation of halothane in rabbit liver microsomes.
    Kawamoto M; Fujii K; Yuge O; Morio M
    Hiroshima J Med Sci; 1989 Dec; 38(4):161-7. PubMed ID: 2637243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reductive halothane metabolite formation and halothane binding in rat hepatic microsomes.
    Baker MT; Van Dyke RA
    Chem Biol Interact; 1984 Apr; 49(1-2):121-32. PubMed ID: 6722932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of volatile halothane metabolites in biological tissues by gas chromatography.
    Maiorino RM; Sipes IG; Gandolfi AJ; Brown BR
    J Chromatogr; 1979 Sep; 164(1):63-72. PubMed ID: 541398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volatile metabolites of halothane in the rabbit.
    Mukai S; Morior M; Fujii K; Hanaki C
    Anesthesiology; 1977 Sep; 47(3):248-51. PubMed ID: 889112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic activation of the halothane metabolite, [14C]2-chloro-1,1-difluoroethene, in hepatic microsomes.
    Baker MT; Bates JN
    Drug Metab Dispos; 1988; 16(2):169-72. PubMed ID: 2898328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient exposure to residual fluorinated anesthetic agents in anesthesia-machine circuits.
    Murray WJ; Fleming P
    Anesth Analg; 1973; 52(1):23-6. PubMed ID: 4734295
    [No Abstract]   [Full Text] [Related]  

  • 15. The release of inorganic fluoride from halothane and halothane metabolites by cytochrome P-450, hemin, and hemoglobin.
    Baker MT; Nelson RM; Van Dyke RA
    Drug Metab Dispos; 1983; 11(4):308-11. PubMed ID: 6137335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of reductive dehalogenation of halothane by liver cytochrome P450.
    Ahr HJ; King LJ; Nastainczyk W; Ullrich V
    Biochem Pharmacol; 1982 Feb; 31(3):383-90. PubMed ID: 7073765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dragons and other scientific hazards.
    Eger EI
    Anesthesiology; 1979 Jan; 50(1):1. PubMed ID: 104640
    [No Abstract]   [Full Text] [Related]  

  • 18. Mutagenicity of the halogenated olefin, 2-bromo-2-chloro-1,1-difluoroethylene, a presumed metabolite of the inhalation anesthetic halothane.
    Garro AJ; Phillips RA
    Mutat Res; 1978 Aug; 54(1):17-22. PubMed ID: 97524
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolism of halothane in children having repeated halothane anaesthetics.
    Plummer JL; Steven IM; Cousins MJ
    Anaesth Intensive Care; 1987 May; 15(2):136-40. PubMed ID: 3605562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guinea-pig model of halothane-associated hepatotoxicity in the absence of enzyme induction and hypoxia.
    Lunam CA; Cousins MJ; Hall PD
    J Pharmacol Exp Ther; 1985 Mar; 232(3):802-9. PubMed ID: 3973829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.